ORBIMED ADVISORS LLC: FOLD position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on FOLD, newest first. How the timeline and the estimate are built.
ORBIMED ADVISORS LLC held 0 FOLD shares at 2026-03-31 per its 13F-HR filed 2026-05-15.
the latest 13F is the newest step
- period ended2026-03-3113F 0 sharesChange vs previous 13F -729,900 shares
13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-12-3113F 729,900 sharesChange vs previous 13F -915,500 shares
0.21% of the 13F portfolio, value $10,393,776.
13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,645,400 sharesChange vs previous 13F -640,000 shares
0.31% of the 13F portfolio, value $12,965,752.
13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,285,400 sharesChange vs previous 13F 0 shares
0.33% of the 13F portfolio, value $13,095,342.
13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 2,285,400 sharesChange vs previous 13F 0 shares
0.45% of the 13F portfolio, value $18,648,864.
13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 2,285,400 sharesChange vs previous 13F +1,715,100 shares
0.45% of the 13F portfolio, value $21,528,468.
13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 570,300 sharesChange vs previous 13F not available
0.11% of the 13F portfolio, value $6,090,804.
13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).